An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Content Removal
Based on TikTok, the service has taken down problematic content and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Investigations also discovered communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at residence.
After moments of joining one community, a seller shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Item Information and Costs
Within these communities, messages show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant health risks”.
